Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.) · Firm: PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.)
H.R. 1968: Full-Year Continuing Appropriations and Extensions Act, 2025; discussions related to federal excise drawback laws. Discussions related to federal excise tax drawback laws and their application to manufacturing of tobacco products.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Discussions related to costs incurred by Medicare & Medicaid for treatment of smoking related diseases; public impact of smoking related diseases and the potential cost savings and improved public health outcomes related to tobacco harm reduction programs and products.
Discussions related to Veterans and health related issues.
Source: Senate LDA
Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to educating adult smokers about smoke-free products, the continuum of risk, and misconceptions about nicotine. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco product and nicotine products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products. Discussions related to the misperception of nicotine in the context of tobacco policy and public health.
Discussions related to tobacco harm reduction pilot programs on military installations. Discussions related to educating adult smokers about smoke-free products, the continuum of risk, and misconceptions about nicotine.
Discussions related to potential tariffs on imported products. Discussions related to non-tariff barriers to trade and related foreign trade issues. Discussions related to foreign environmental certification.
Filing targets: Alcohol & Tobacco Tax & Trade Bureau (TTB), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.) via PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.)
2026 · second_quarter · Q2
Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to educating adult smokers about smoke-free products, the continuum of risk, and misconceptions about nicotine. Discussions related to efforts to address smoking rates in certain populations where there has not been a meaningful decline. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco product and nicotine products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products. Discussions related to the misperception of nicotine in the context of tobacco policy and public health.
Discussions related to potential tariffs on imported products. Discussions related to non-tariff barriers to trade and related foreign trade issues. Discussions related to foreign environmental certification.
Discussions related to tobacco harm reduction on military installations. Discussions related to educating adult smokers about smoke-free products, the continuum of risk, and misconceptions about nicotine.
Discussions related to Veterans and health related issues.
Discussions related to costs incurred by Medicare & Medicaid for treatment of smoking related diseases; public impact of smoking related diseases and the potential cost savings and improved public health outcomes related to tobacco harm reduction programs and products.
Filing targets: Alcohol & Tobacco Tax & Trade Bureau (TTB), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to educating adult smokers about smoke-free products, the continuum of risk, and misconceptions about nicotine. Discussions related to efforts to address smoking rates in certain populations where there has not been a meaningful decline. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco product and nicotine products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products. Discussions related to the misperception of nicotine in the context of tobacco policy and public health.
Discussions related to Veterans and health related issues.
Discussions related to tobacco harm reduction on military installations. Discussions related to educating adult smokers about smoke-free products, the continuum of risk, and misconceptions about nicotine.
Discussions related to potential tariffs on imported products. Discussions related to non-tariff barriers to trade and related foreign trade issues. Discussions related to foreign environmental certification.
Discussions related to costs incurred by Medicare & Medicaid for treatment of smoking related diseases; public impact of smoking related diseases and the potential cost savings and improved public health outcomes related to tobacco harm reduction programs and products.
Filing targets: Alcohol & Tobacco Tax & Trade Bureau (TTB), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Discussions related to tobacco harm reduction on military installations. Discussions related to educating adult smokers about smoke-free products, the continuum of risk, and misconceptions about nicotine.
Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to educating adult smokers about smoke-free products, the continuum of risk, and misconceptions about nicotine. Discussions related to efforts to address smoking rates in certain populations where there has not been a meaningful decline. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco product and nicotine products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products. Discussions related to the misperception of nicotine in the context of tobacco policy and public health.
Discussions related to costs incurred by Medicare & Medicaid for treatment of smoking related diseases; public impact of smoking related diseases and the potential cost savings and improved public health outcomes related to tobacco harm reduction programs and products.
Discussions related to potential tariffs on imported products. Discussions related to non-tariff barriers to trade and related foreign trade issues. Discussions related to foreign environmental certification.
Discussions related to Veterans and health related issues.
Filing targets: Alcohol & Tobacco Tax & Trade Bureau (TTB), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.) via PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.)
2025 · fourth_quarter · Q4
Discussions related to costs incurred by Medicare & Medicaid for treatment of smoking related diseases; public impact of smoking related diseases and the potential cost savings and improved public health outcomes related to tobacco harm reduction programs and products.
Discussions related to tobacco harm reduction pilot programs on military installations.
Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco product and nicotine products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products. Discussions related to the misperception of nicotine in the context of tobacco policy and public health.
Discussions related to Veterans and health related issues.
Filing targets: Alcohol & Tobacco Tax & Trade Bureau (TTB), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Discussions related to costs incurred by Medicare & Medicaid for treatment of smoking related diseases; public impact of smoking related diseases and the potential cost savings and improved public health outcomes related to tobacco harm reduction programs and products.
Discussions related to tobacco harm reduction pilot programs on military installations.
Discussions related to U.S. policy guidance provided to executive branch personnel regarding foreign government engagements.
PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.) via PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.)
2025 · second_quarter · Q2
Discussions related to tobacco harm reduction pilot programs on military installations.
Discussions related to U.S. policy guidance provided to executive branch personnel regarding foreign government engagements.
Discussions related to costs incurred by Medicare & Medicaid for treatment of smoking related diseases; public impact of smoking related diseases and the potential cost savings and improved public health outcomes related to tobacco harm reduction programs and products.
H.R. 1968: Full-Year Continuing Appropriations and Extensions Act, 2025; discussions related to federal excise drawback laws. Discussions related to federal excise tax drawback laws and their application to manufacturing of tobacco products.
Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products.
Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco product and nicotine products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products. Discussions related to the misperception of nicotine in the context of tobacco policy and public health.
Discussions related to Veterans and health related issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco product and nicotine products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products. Discussions related to the misperception of nicotine in the context of tobacco policy and public health.
Discussions related to Veterans and health related issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office